Capstone Financial Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $529K | Buy |
1,503
+3
| +0.2% | +$1.07K | 0.03% | 98 |
|
|
2025
Q4 | $491K | Buy |
1,500
+4
| +0.3% | +$1.27K | 0.03% | 97 |
|
|
2025
Q3 | $422K | Buy |
1,496
+10
| +0.7% | +$2.9K | 0.02% | 110 |
|
|
2025
Q2 | $415K | Sell |
1,486
-182
| -11% | -$51.6K | 0.02% | 107 |
|
|
2025
Q1 | $520K | Buy |
1,668
+3
| +0.2% | +$886 | 0.03% | 90 |
|
|
2024
Q4 | $434K | Sell |
1,665
-656
| -28% | -$195K | 0.03% | 95 |
|
|
2024
Q3 | $748K | Buy |
2,321
+393
| +20% | +$129K | 0.05% | 74 |
|
|
2024
Q2 | $602K | Buy |
1,928
+3
| +0.2% | +$881 | 0.04% | 77 |
|
|
2024
Q1 | $547K | Buy |
1,925
+47
| +3% | +$13.8K | 0.04% | 80 |
|
|
2023
Q4 | $541K | Buy |
1,878
+3
| +0.2% | +$817 | 0.04% | 78 |
|
|
2023
Q3 | $504K | Sell |
1,875
-161
| -8% | -$40.2K | 0.04% | 75 |
|
|
2023
Q2 | $452K | Sell |
2,036
-71
| -3% | -$16.5K | 0.03% | 82 |
|
|
2023
Q1 | $509K | Sell |
2,107
-147
| -7% | -$36.1K | 0.04% | 71 |
|
|
2022
Q4 | $592K | Sell |
2,254
-306
| -12% | -$82K | 0.05% | 63 |
|
|
2022
Q3 | $577K | Sell |
2,560
-39
| -2% | -$9.45K | 0.05% | 63 |
|
|
2022
Q2 | $632K | Buy |
2,599
+5
| +0.2% | +$1.23K | 0.05% | 65 |
|
|
2022
Q1 | $627K | Buy |
2,594
+10
| +0.4% | +$2.3K | 0.05% | 66 |
|
|
2021
Q4 | $581K | Buy |
2,584
+295
| +13% | +$62.3K | 0.04% | 69 |
|
|
2021
Q3 | $487K | Buy |
2,289
+321
| +16% | +$73.9K | 0.04% | 70 |
|
|
2021
Q2 | $480K | Buy |
1,968
+46
| +2% | +$11.3K | 0.04% | 72 |
|
|
2021
Q1 | $478K | Buy |
1,922
+18
| +0.9% | +$4.29K | 0.04% | 64 |
|
|
2020
Q4 | $438K | Buy |
1,904
+253
| +15% | +$58.3K | 0.04% | 65 |
|
|
2020
Q3 | $420K | Buy |
1,651
+1
| +0.1% | +$248 | 0.04% | 54 |
|
|
2020
Q2 | $389K | Buy |
1,650
+2
| +0.1% | +$456 | 0.04% | 50 |
|
|
2020
Q1 | $334K | Buy |
1,648
+170
| +12% | +$37.1K | 0.04% | 48 |
|
|
2019
Q4 | $356K | Buy |
1,478
+2
| +0.1% | +$441 | 0.05% | 57 |
|
|
2019
Q3 | $286K | Sell |
1,476
-84
| -5% | -$16.1K | 0.04% | 67 |
|
|
2019
Q2 | $287K | Sell |
1,560
-84
| -5% | -$15K | 0.05% | 65 |
|
|
2019
Q1 | $312K | Buy |
1,644
+173
| +12% | +$33K | 0.05% | 61 |
|
|
2018
Q4 | $286K | Buy |
1,471
+152
| +12% | +$29.7K | 0.06% | 59 |
|
|
2018
Q3 | $273K | Buy |
1,319
+1
| +0.1% | +$197 | 0.07% | 62 |
|
|
2018
Q2 | $243K | Sell |
1,318
-352
| -21% | -$62.3K | 0.07% | 64 |
|
|
2018
Q1 | $285K | Sell |
1,670
-85
| -5% | -$15.6K | 0.09% | 54 |
|
|
2017
Q4 | $305K | Sell |
1,755
-111
| -6% | -$19.6K | 0.11% | 52 |
|
|
2017
Q3 | $348K | Buy |
1,866
+349
| +23% | +$61.8K | 0.15% | 46 |
|
|
2017
Q2 | $261K | Sell |
1,517
-93
| -6% | -$15.1K | 0.13% | 54 |
|
|
2017
Q1 | $264K | Sell |
1,610
-101
| -6% | -$16.8K | 0.13% | 47 |
|
|
2016
Q4 | $250K | Sell |
1,711
-98
| -5% | -$14.7K | 0.11% | 53 |
|
|
2016
Q3 | $302K | Sell |
1,809
-22
| -1% | -$3.72K | 0.16% | 45 |
|
|
2016
Q2 | $279K | Sell |
1,831
-94
| -5% | -$14.6K | 0.15% | 46 |
|
|
2016
Q1 | $289K | Buy |
1,925
+204
| +12% | +$30.3K | 0.11% | 50 |
|
|
2015
Q4 | $279K | Buy |
1,721
+45
| +3% | +$7.07K | 0.1% | 49 |
|
|
2015
Q3 | $232K | Sell |
1,676
-31
| -2% | -$4.89K | 0.1% | 53 |
|
|
2015
Q2 | $262K | Sell |
1,707
-501
| -23% | -$80.3K | 0.1% | 64 |
|
|
2015
Q1 | $353K | Buy |
2,208
+4
| +0.2% | +$630 | 0.14% | 51 |
|
|
2014
Q4 | $351K | Buy |
2,204
+712
| +48% | +$111K | 0.11% | 50 |
|
|
2014
Q3 | $210K | Buy |
+1,492
| New | +$195K | 0.13% | 52 |
|
Other funds holding AMGN
VCM
VPM
Capstone Financial Advisors's AMGN Position: Q1 2026 in Review
Capstone Financial Advisors increased its Amgen (AMGN) stake by 0.2% in Q1 2026, buying an estimated $1.07K and bringing the position to 1,503 shares worth $529K. The position accounts for 0.03% of the portfolio, ranked #98.
Capstone Financial Advisors first reported a position in AMGN in Q3 2014 and has held it in 47 quarters since. The position peaked at $748K in Q3 2024. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Capstone Financial Advisors held 1,503 shares of Amgen worth $529K as of Q1 2026.
- Capstone Financial Advisors bought 3 Amgen shares in Q1 2026, an estimated $1.07K.
- Amgen made up 0.03% of Capstone Financial Advisors's portfolio in Q1 2026, its #98 holding.
- Capstone Financial Advisors first reported a position in Amgen in Q3 2014 and has held it in 47 quarters since.
- Capstone Financial Advisors's Amgen position peaked at $748K in Q3 2024.
- 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Capstone Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.